Genomictree Market Cap

Genomictree has a market cap or net worth of 296.2 billion as of June 10, 2026. Its market cap has decreased by -15.48% in one year.

Market Cap

296.20B

Enterprise Value

221.18B

Revenue

3.83B

Ranking

n/a

PE Ratio

n/a

Stock Price

12,090.00

Market Cap Chart

Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 296.20B, an increase of 402.04%. That is a compound annual growth rate of 19.21%.

Market Cap History

Date	Market Cap	% Change
Jun 9, 2026	289.09B	-56.16%
Dec 30, 2025	659.41B	34.41%
Dec 30, 2024	490.60B	0.78%
Dec 28, 2023	486.82B	168.25%
Dec 29, 2022	181.48B	-32.87%
Dec 30, 2021	270.36B	-7.66%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Apr 5, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
MEDIPOST	416.65B
Proteina	411.87B
SillaJen	363.01B
Anterogen.Co.,Ltd.	264.16B
BINEX	261.47B
GC Cell	258.17B
NeoImmuneTech	247.66B
HLB Therapeutics	245.76B

Market Cap Rankings